FLT3 Y842H
|
AML
|
FLT3 Y842H
|
AML
|
quizartinib Resistant: C3 – Early Trials
|
quizartinib Resistant: C3 – Early Trials
|
FLT3 Y842H
|
AML
|
FLT3 Y842H
|
AML
|
ponatinib Resistant: D – Preclinical
|
ponatinib Resistant: D – Preclinical
|